Send feedback

CAVIN1 p.Val119Asp

c.356T>A · rs146547678 · VCV193361

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 11 submitters
AlphaMissense
likely pathogenic
0.9124 · ACMG-weighted
gnomAD v4.1
Rare
rare (popmax 0.334%, nfe)
Missense predictors
1/2 damaging
AlphaMissense, SaProt · REVEL indeterminate
Conditions
1
congenital generalized lipodystrophy type 4

Computational evidence

Protein change
AlphaMissense0.9124likely pathogenic
REVEL0.301indeterminate
SaProtLLR -8.52tolerated
⇒ AlphaMissense calls this damaging; SaProt does not; REVEL is indeterminate.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 6GERP -3, phastCons 1
Regional constrainto/e 0.92unconstrained · MANE · 18 kb · p 0.076 · regional, not allelic
Overall
CADD28.7PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.334% European (non-Finnish) · 3,942/1,179,130 alleles
Filtering AF 0.326% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.322%
Overall 0.28% 4,515/1,611,682 alleles · rare exomes 4,213/1,459,434 · genomes 302/152,248 · joint denominator
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 0.365% 274
European (non-Finnish)grpmax 0.334% 299
Remaining individualsnot grpmax-eligible 0.264% 378
Ashkenazi Jewishnot grpmax-eligible 0.156% 642
Admixed American 0.134% 746
Middle Eastern 0.0826% 1,211
African / African-American 0.0534% 1,874
South Asian 0.00552% 18,131

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CAVIN1
Protein
p.Val119Asp
Coding
c.356T>A
MANE Select
NM_012232
dbSNP
rs146547678
Type
single nucleotide variant
Location
chr17:42422742 (GRCh38)
Gene constraint
LOEUF 1.092 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 68.03 · 3 PDB
Full CAVIN1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cavin1-p-val119asp (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown